Clik here to view.
Horizon raises the bar for biotech with recruitment spree
Gene editing world leader Horizon Discovery has triggered the biggest search for talent in the company's near-10 year history.It is underpinning the recruitment drive with a remuneration and benefits...
View ArticleClik here to view.
Z Factor raises £7m to bring lung treatment to clinic
Z Factor, a Cambridge University spin-out, has raised £7 million to discover new drugs to fight liver and lung disease caused by a major gene defect.The Series A has been led by existing investor...
View ArticleClik here to view.
Siemens strikes cyber security alliance with Darktrace
Siemens has joined forces with Cambridge UK cyber security business Darktrace to strengthen the digital defences of vulnerable electric utilities and oil & gas companies.The energy and utility...
View ArticleClik here to view.
AstraZeneca in US alliance to counter respiratory diseases
AstraZeneca, whose new headquarters is in Cambridge UK, has agreed a strategic collaboration in respiratory diseases with Boston-based Pieris Pharmaceuticals Inc.They plan to develop novel inhaled...
View ArticleClik here to view.
Tech triage threat as Amazon prepares giant new Cambridge hub with room for...
Amazon’s decision to expand with a new 60,000 sq ft development centre near Cambridge rail station with capacity for 400 tech staff is set to trigger a survival of the fittest scenario in the UK...
View ArticleClik here to view.
Horizon set for $multimillion immuno-oncology boom
Cambridge’s gene editing world leader Horizon Discovery has laid the foundations for a stratospheric rise in revenues from its transformational immuno-oncology platform.The UK business has already...
View ArticleClik here to view.
Treatt plc three years ahead of 2020 growth targets
Suffolk manufacturer Treatt plc has hit a revenue peak that puts it three years ahead of global growth targets set out in its 2020 vision.The company is expanding in both the UK and US as demand...
View ArticleClik here to view.
Augmented reality sets up X-ray vision surgery
The latest in a series of surgical innovations from product design and development firm Cambridge Consultants is exploring how augmented reality (AR) could transform surgery. The company is showcasing...
View ArticleClik here to view.
UltraSoc to scale and recruit after raising $6.4m
Cambridge business UltraSoC has completed a £5 million ($6.4m) funding round to drive continued deployment of its technology and realise its vision of embedding intelligent analytics capabilities into...
View ArticleClik here to view.
ARM kickstarts AI revolution and could ship 100bn chips in five years
Cambridge superchip architect ARM today launched a new technology suite designed to revolutionise the global use of Artificial Intelligence, delivering virtual reality capabilities to a range of...
View ArticleClik here to view.
Bicycle Therapeutics raises $52m Series B cash
Big hitting California and Singapore investor Vertex Ventures HC has led a $52 million (£40m) Series B round for Cambridge UK biotech business Bicycle Therapeutics to accelerate development of multiple...
View ArticleClik here to view.
Cambridge role in new Apple Siri speaker?
We may find out next week exactly why Apple was minded to pay up to $100 million for Cambridge speech recognition technology startup VocalIQ in October 2015 – a deal it is fair to say that stunned most...
View ArticleClik here to view.
US-owned biotech plans to scale in Cambridge
Proximagen, which specialises in novel small molecule therapeutics – notably for CNS, pain and inflammation – plans to scale further from its Cambridge UK base as part of an ongoing global expansion...
View ArticleClik here to view.
The ugly truth about effective marketing
I was reading an article in the Huffington Post entitled ‘Why Women Gladly Date Ugly Men (and Often Prefer Them)’ which gave me new hope and set me thinking about the real and the ideal, not just in...
View ArticleClik here to view.
F-star tees up potential €1bn antibodies windfall from Merck
Cambridge antibodies business F-star has clinched a €115 million initial deal with global giant Merck that could cascade into a €1 billion bonanza.The UK company, named Life Science Innovation champion...
View ArticleClik here to view.
Setting up a corporate foundation: key considerations
Corporate Social Responsibility is an important issue for businesses, with consumers and investors increasingly concerned about where they spend or invest their money, writes Liz Brownsell, senior...
View ArticleClik here to view.
The rise of InsurTech
In recent years, InsurTech has acted as an increasingly disruptive influence in the insurance sector, using technology and innovation to improve the efficiency of existing transactions and processes...
View ArticleClik here to view.
The morning after – the political gamble that went so wrong
Unfortunately despite presenting themselves as the safe, “Strong and stable”, option, the Conservatives have taken a second huge political gamble which has gone spectacularly wrong, leaving the public...
View ArticleClik here to view.
Cambridge crowdfunder closes three deals for £4.3m in a week
Cambridge online investment platform SyndicateRoom has completed a trio of deals aggregating to £4.3 million in a heady seven days.The first two represented the closure of two lift rounds for...
View ArticleClik here to view.
Consort Medical almost doubles profits and hikes dividend
Drug and delivery device business Consort Medical plc almost doubled pre-tax profits to £21.9 million in the year to April 30 on revenues 6.2 per cent ahead at £294m.Consort is based in Cambridge and...
View Article